1. Home
  2. WST vs BAP Comparison

WST vs BAP Comparison

Compare WST & BAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BAP
  • Stock Information
  • Founded
  • WST 1923
  • BAP 1889
  • Country
  • WST United States
  • BAP Peru
  • Employees
  • WST N/A
  • BAP N/A
  • Industry
  • WST Medical/Dental Instruments
  • BAP Major Banks
  • Sector
  • WST Health Care
  • BAP Finance
  • Exchange
  • WST Nasdaq
  • BAP Nasdaq
  • Market Cap
  • WST 18.9B
  • BAP 19.3B
  • IPO Year
  • WST N/A
  • BAP 1995
  • Fundamental
  • Price
  • WST $250.86
  • BAP $261.20
  • Analyst Decision
  • WST Buy
  • BAP Buy
  • Analyst Count
  • WST 7
  • BAP 6
  • Target Price
  • WST $332.50
  • BAP $234.83
  • AVG Volume (30 Days)
  • WST 501.4K
  • BAP 384.1K
  • Earning Date
  • WST 10-23-2025
  • BAP 11-06-2025
  • Dividend Yield
  • WST 0.35%
  • BAP 4.22%
  • EPS Growth
  • WST N/A
  • BAP 26.90
  • EPS
  • WST 6.68
  • BAP 22.19
  • Revenue
  • WST $2,960,200,000.00
  • BAP $5,576,317,301.00
  • Revenue This Year
  • WST $6.28
  • BAP $25.32
  • Revenue Next Year
  • WST $6.02
  • BAP $6.46
  • P/E Ratio
  • WST $37.51
  • BAP $11.77
  • Revenue Growth
  • WST 2.90
  • BAP 19.15
  • 52 Week Low
  • WST $187.43
  • BAP $165.51
  • 52 Week High
  • WST $352.33
  • BAP $263.92
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.03
  • BAP 71.21
  • Support Level
  • WST $241.64
  • BAP $249.59
  • Resistance Level
  • WST $248.66
  • BAP $263.92
  • Average True Range (ATR)
  • WST 4.85
  • BAP 5.40
  • MACD
  • WST -0.17
  • BAP 0.05
  • Stochastic Oscillator
  • WST 92.22
  • BAP 83.87

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BAP Credicorp Ltd.

Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.

Share on Social Networks: